Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FET-PET in Low Grade Glioma Diagnosis
NCT02286531Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jun 2010
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
Single-blind, single-arm trial, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Overall discriminating capacity of FET-PET in the diagnosis of glioma grade II. Started Jun 2010; status: completed.
Beyond the preview
Go deeper on NCT02286531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286531.